| |
Saturday, April 17th, 2021 |
| |
POTPOURRI |
| |
13:20 |
Office Injections for Headaches |
Yasmine Hoydonckx |
| |
OBJECTIVES: |
By the end of this lecture participants will be able to:
- Briefly categorize headache disorders
- Provide evidence supporting office-based headache injections and interventional options
- Discuss appropriate patient selection and procedural details
|
| |
13:45 |
Pelvic Pain / Pudendal Neuralgia |
Sonja Bodmer-Roy |
| |
OBJECTIVES: |
By the end of this lecture participants will be able to:
- Describe the most common chronic pelvic pain syndromes
- Outline the prevalence of pudendal neuralgia and list its therapeutic approaches
|
| |
14:10 |
Complex Regional Pain Syndrome |
Jordi Perez |
| |
OBJECTIVES: |
By the end of this lecture participants will be able to:
- Understand the relevance of the autonomous nervous system in the generation and perpetuation of chronic pain syndromes with special attention to CRPS
- Be able to identify the potential anatomical targets to block the sympathetic chain
- Appraise the most common pain syndromes where sympathetic nerve blocks are indicated.
|
| |
14:35 |
Panel Discussion |
| |
14:50 |
Refreshments and Exhibits |
| |
15:05 |
Neuromodulation: an overview |
François Fugère |
| |
OBJECTIVES: |
By the end of this lecture participants will be able to:
- Describe main technologies involved in neuromodulation for pain
- List the indications and contraindications of neuromodulation
- Identify strategies to improve long-term SCS success
|
| |
15:30 |
Regenerative Medicine |
Neilesh Soneji |
| |
OBJECTIVES: |
By the end of this lecture participants will be able to:
- Define Platelet Rich Plasma (PRP)
- Review the biological mechanisms of action of PRP
- Review the evidence for PRP in OA
- Review the evidence for PRP in tendinopathy
- Explain the risks of PRP
|
| |
15:55 |
Panel Discussion |
| |
16:10 - 16:20 |
Closing Remarks |
